Kyverna Therapeutics, Inc. Common Stock (KYTX) Stock Analysis

Kyverna Therapeutics, Inc. Common Stock (KYTX) is a publicly traded company in the HEALTHCARE sector. It trades at $7.90, carries a market capitalization of $499.74M. This page summarizes the public market data, fundamentals, and frequently asked questions for KYTX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $7.90
• Market Cap: $499.74M
• EPS: $-3.27
• 52-Week High: $13.67
• 52-Week Low: $2.52

Market Sentiment

Kyverna Therapeutics, Inc. Common Stock currently has a Neutral sentiment score of 0.04.

About Kyverna Therapeutics, Inc. Common Stock

None

GNG Research Analysis

GNG Research scores Kyverna Therapeutics, Inc. Common Stock (KYTX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for KYTX.

Frequently Asked Questions

Does KYTX pay dividends?

Kyverna Therapeutics, Inc. Common Stock (KYTX) does not currently pay a regular dividend.

What is KYTX's market cap?

Kyverna Therapeutics, Inc. Common Stock (KYTX) has a market capitalization of $499.74M with a current stock price of $7.90.